Market research
1TT.F Factor Therapeutics Limited
F EUR Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 52M
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.48
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- Not available
- Market cap
- 52M
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.48
About
About Factor Therapeutics Limited
Dominion Minerals Limited, together with its subsidiary, engages in the exploration of mineral properties. It holds an option to purchase a high calcium limestone project located in Early County, south Georgia. The company was formerly known as Factor Therapeutics Limited and changed its name to Dominion Minerals Limited in September 2021. Dominion Minerals Limited was incorporated in 2002 and is based in Brisbane, Australia.
Research context
Factor Therapeutics Limited appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 1TT.F discussion.
5 years, 6 months ago
Factor Therapeutics Limited is currently in a long term uptrend where the price is trading 87.1% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Its net income has dropped by 0.0% to $-179K since the same quarter in the previous year.
Finally, its free cash flow grew by 22.1% to $-125K since the same quarter in the previous year.
Based on the above factors, Factor Therapeutics Limited gets an overall score of 3/5.